Cargando…

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis

The use of antihuman T-lymphocyte immunoglobulin in the setting of transplantation from an HLA-matched related donor is still much debated. Acute and chronic graft-versus-host disease are the main causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robin, Marie, Chevret, Sylvie, Koster, Linda, Wolschke, Christine, Yakoub-Agha, Ibrahim, Bourhis, Jean Henri, Chevallier, Patrice, Cornelissen, Jan J., Reményi, Péter, Maertens, Johan, Poiré, Xavier, Craddock, Charles, Socié, Gérard, Itälä-Remes, Maija, Schouten, Harry C., Marchand, Tony, Passweg, Jakob, Blaise, Didier, Damaj, Gandhi, Ozkurt, Zubeyde Nur, Zuckerman, Tsila, Cluzeau, Thomas, Labussière-Wallet, Hélène, Cammenga, Jörg, McLornan, Donal, Chalandon, Yves, Kröger, Nicolaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545844/ https://www.ncbi.nlm.nih.gov/pubmed/30655365 http://dx.doi.org/10.3324/haematol.2018.201400

Ejemplares similares

Antilymphocytic Serum
por: Lipsmeyer, Eleanor A.
Publicado: (1968)

Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
por: Schmaelter, Ann-Kristin, et al.
Publicado: (2020)

State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019
por: McLornan, Donal P., et al.
Publicado: (2019)

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT
por: Pavlů, Jiří, et al.
Publicado: (2019)

HISTOPATHOLOGICAL EFFECTS IN MICE OF HETEROLOGOUS ANTILYMPHOCYTE SERUM
por: Taub, Robert N., et al.
Publicado: (1968)

SUPPRESSION OF ADJUVANT DISEASE IN THE RAT BY HETEROLOGOUS ANTILYMPHOCYTE GLOBULIN
por: Currey, H. L. F., et al.
Publicado: (1968)

Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT
por: Robin, Marie, et al.
Publicado: (2023)

Abrogation of the anti-metastatic activity of C. parvum by antilymphocyte serum.
por: Sadler, T. E., et al.
Publicado: (1976)

Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
por: Halaburda, Kazimierz, et al.
Publicado: (2020)

Transplantation of Primary Explants of Human Tumour to Mice Treated with Antilymphocyte Serum
por: Phillips, B., et al.
Publicado: (1970)

Antilymphocyte Antibodies in Systemic Lupus Erythematosus: Association with Disease Activity and Lymphopenia
por: Li, Chun, et al.
Publicado: (2014)

Comment faire face à un événement inattendu pouvant modifier l’activité normale de thérapie cellulaire ? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
por: Bay, Jacques Olivier, et al.
Publicado: (2021)

Long-term Survival of HeLa Tumours in Mice Treated with Antilymphocyte Serum
por: Franks, C. R., et al.
Publicado: (1973)

THE PROVOCATION OF LATENT LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTIONS IN MICE BY TREATMENT WITH ANTILYMPHOCYTIC SERUM
por: Volkert, Mogens, et al.
Publicado: (1968)

CELL TO CELL INTERACTION IN THE IMMUNE RESPONSE : IV. SITE OF ACTION OF ANTILYMPHOCYTE GLOBULIN
por: Martin, W. J., et al.
Publicado: (1968)

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
por: Robin, Marie, et al.
Publicado: (2019)

Isolation of a murine hepatitis virus from Swiss mice treated with antilymphocyte serum
por: van der Riet, F. de St. J., et al.
Publicado: (1973)

Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT
por: Chalandon, Yves, et al.
Publicado: (2022)

Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT
por: Masouridi-Levrat, Stavroula, et al.
Publicado: (2021)

Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?
por: McLornan, Donal, et al.
Publicado: (2013)

Apoptotic Effects of Antilymphocyte Globulins on Human Pro-inflammatory CD4(+)CD28(−) T-cells
por: Duftner, Christina, et al.
Publicado: (2012)

Intravesical recurrence of chromophobe renal cell carcinoma
por: Kelly, Niall P., et al.
Publicado: (2023)

Heterologous Antilymphocyte Serum Hastens the Growth of 7,12-Dimethylbenz(α)Anthracene Induced Tumours in Mice
por: Baroni, C. D., et al.
Publicado: (1973)

Measurable residual disease, FLT3‐ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1‐mutated acute myeloid leukemia
por: Al Hamed, Rama, et al.
Publicado: (2022)

Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study
por: Ruutu, Tapani, et al.
Publicado: (2023)

Urosepsis and the urologist!
por: Ryan, James, et al.
Publicado: (2021)

Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT
por: Hirschbühl, Klaus, et al.
Publicado: (2023)

Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
por: Kröger, Nicolaus, et al.
Publicado: (2021)

JAK2 V617F: A Single Mutation in the Myeloproliferative Group of Disorders
por: McLornan, Donal, et al.
Publicado: (2006)

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
por: Bassiony, Sarah, et al.
Publicado: (2020)

Bone marrow niche dysregulation in myeloproliferative neoplasms
por: Curto-Garcia, Natalia, et al.
Publicado: (2020)

Implementation of telemedicine in response to COVID-19 in a Dublin hospital - A patient perspective
por: Horan, M., et al.
Publicado: (2021)

The Effect of Granulocyte Colony-Stimulating Factor (G-CSF) on Early Complications and Graft-Versus-Host Disease (GVHD) in Allogeneic Stem Cell Transplantation (ASCT) Recipients
por: Aydın Kaynar, Lale, et al.
Publicado: (2023)

Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
por: Poiré, Xavier, et al.
Publicado: (2017)

Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
por: Poiré, Xavier, et al.
Publicado: (2018)

Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT
por: Drozd-Sokołowska, Joanna, et al.
Publicado: (2022)

A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies
por: Özkurt, Zübeyde Nur, et al.
Publicado: (2016)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

How to Transform an Exceptional Case Report Into a Therapy: Following the Frog Out of the Box
por: Heiblig, Maël, et al.
Publicado: (2021)

The impact of COVID-19 on acute urinary stone presentations: a single-centre experience
por: Anderson, Steven, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u46irhla0914uidjbnsm2gtkbt